Podcast: ‘What The Health?’ Why Is It So Difficult To Control Drug Prices?

Clockwise from left, Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Julie Appleby of KHN, and Sarah Karlin-Smith of Politico. (Caitlin Hillyard/KHN)

Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the recent extension of cost-sharing subsidies for millions of low-income beneficiaries on the Affordable Care Act’s marketplaces — as well as the state of play on Capitol Hill and in the states concerning efforts to lower prescription drug costs.

Plus, for “extra credit,� the panelists recommend their favorite health stories of the week they think you should read, too.

Mary Agnes Carey:ÌýKaiser Health News’ “,” by JoNel Aleccia.

Margot Sanger-Katz:Ìýµþ±ô´Ç´Ç³¾²ú±ð°ù²µ’²õÌý“,” by Hannah Recht.

Sarah Karlin-Smith: TheÌýNew York Times’Ìý“,”Ìýby Gina Kolata.

Julie Appleby: TheÌýWall Street Journal’sÌý“,”Ìýby Denise Roland.

To hear all our podcasts,Ìý.

And subscribe to What the Health? onÌý,ÌýÌýorÌý.

Related Topics

Health IndustryAffordable Care ActDrug CostsDrugsMultimediaPodcastsSubsidiesU.S. CongressRepeal And Replace WatchWhat the Health? From 51ÊÓÆµ Health News

More from 51ÊÓÆµ Health News